Eli Lilly and Company (LLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2016 | 06-2016 | 03-2016 | 12-2015 | 09-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,965,800 | 1,187,800 | 440,100 | 2,408,400 | 1,930,000 |
| Depreciation Amortization | 1,152,000 | 759,200 | 385,500 | 1,427,700 | 1,084,300 |
| Income taxes - deferred | 350,800 | 168,600 | 30,600 | -748,400 | -671,000 |
| Accounts receivable | N/A | N/A | N/A | -304,500 | N/A |
| Accounts payable and accrued liabilities | N/A | N/A | N/A | 207,900 | N/A |
| Other Working Capital | -1,110,800 | -1,296,500 | -1,382,900 | -1,139,200 | -684,100 |
| Other Operating Activity | 486,700 | 363,700 | 307,600 | 1,112,700 | 309,300 |
| Operating Cash Flow | $2,844,500 | $1,182,800 | $-219,100 | $2,964,600 | $1,968,500 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 820,200 | 660,100 | 423,200 | 1,319,600 | 821,600 |
| PPE Investments | -627,200 | -399,700 | -154,300 | -973,600 | -686,000 |
| Net Acquisitions | -45,000 | -45,000 | N/A | -5,283,100 | -5,287,800 |
| Purchase Of Investment | -3,640,700 | -2,269,200 | -716,700 | -3,226,500 | -2,673,400 |
| Sale Of Investment | 1,606,800 | 919,300 | 338,900 | 3,068,400 | 2,271,800 |
| Purchase Sale Intangibles | N/A | N/A | N/A | 410,000 | 410,000 |
| Other Investing Activity | -75,100 | -31,800 | -36,500 | 5,122,000 | 5,326,900 |
| Investing Cash Flow | $-1,961,000 | $-1,166,300 | $-145,400 | $26,800 | $-226,900 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -1,700 | -1,400 | -1,100 | -2,680,600 | -2,680,700 |
| Debt Issued | 1,206,600 | 1,206,600 | N/A | 4,454,700 | 2,504,000 |
| Debt Repayment | -200 | -100 | N/A | -1,955,700 | N/A |
| Common Stock Repurchased | -300,100 | -300,100 | -300,100 | -749,500 | -496,600 |
| Dividend Paid | -1,617,400 | -1,079,500 | -538,300 | -2,127,300 | -1,594,000 |
| Other Financing Activity | -232,200 | -170,400 | -84,700 | -52,600 | 27,700 |
| Financing Cash Flow | $-945,000 | $-344,900 | $-924,200 | $-3,111,000 | $-2,239,600 |
| Exchange Rate Effect | -115,900 | -100,000 | -70,100 | -85,600 | -134,800 |
| Beginning Cash Position | 3,666,400 | 3,666,400 | 3,666,400 | 3,871,600 | 3,871,600 |
| End Cash Position | 3,489,000 | 3,238,000 | 2,307,600 | 3,666,400 | 3,238,800 |
| Net Cash Flow | $-177,400 | $-428,400 | $-1,358,800 | $-205,200 | $-632,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,844,500 | 1,182,800 | -219,100 | 2,964,600 | 1,968,500 |
| Capital Expenditure | -627,200 | -399,700 | -154,300 | -1,066,200 | -686,000 |
| Free Cash Flow | 2,217,300 | 783,100 | -373,400 | 1,898,400 | 1,282,500 |